Ptc Therapeutics | search
Click here to view Ptc Therapeutics news from 60+ newspapers.
Bookmark or Share- PTC Therapeutics - WikipediaPTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
- PTC Therapeutics | Pioneers in Rare Disease TreatmentsMaking headlines. PTC Therapeutics pioneers pharmaceutical science to transform lives and treat rare diseases, like Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Huntington's Disease, Leukemia, and more.
- PTC Therapeutics - The Complete History of PTC Since 1998PTC Therapeutics was founded in 1998 focused on leveraging its expertise in RNA biology to discover and develop treatments for patients living with rare diseases. In the first 25 years, PTC achieved historic breakthroughs in the treatment of several rare diseases such as Duchenne muscular dystrophy, spinal muscular atrophy and aromatic l-amino ...
- Our Pipeline - PTC TherapeuticsPTC has been a pioneer in the development of breakthrough rare disease therapies, delivering a number of firsts for patients who previously had no other treatment options. Our strategy leverages our innovative scientific knowledge, our deep therapeutic expertise and robust global commercial infrastructure.
- About PTC Therapeutics - Treatments for Rare DiseasesLearn about PTC Therapeutics, a global biopharmaceutical company. We are fueled by science, and committed to transforming the lives of patients with rare diseases.
More
